🕵️ Enanta Pharmaceuticals Inc ($ENTA)
SEC insider & ownership activity, last 12 months · CIK 1177648 · every row links its SEC filing
Over the last 12 months insiders sold $183K with no open-market buying against it. Jay R. Luly sold $67K in discretionary trades (Dec). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 7 sellers, $183K (9 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Jay R. Luly | 0 | – | 1 | $67K | Dec 5, 2025 |
| Or Yat Sun | 0 | – | 1 | $34K | Dec 5, 2025 |
| Kieffer Tara Lynn | 0 | – | 1 | $30K | Dec 5, 2025 |
| Luu Brendan | 0 | – | 1 | $20K | Dec 5, 2025 |
| Harry R. Trout III | 0 | – | 2 | $13K | Dec 5, 2025 |
| Scott T. Rottinghaus | 0 | – | 1 | $11K | Dec 5, 2025 |
| Kathleen S. Capps | 0 | – | 2 | $7K | Dec 5, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Janus Henderson Group PLC | 12.1% | 13G | Nov 7, 2025 | filing ↗ | |
| Janus Henderson Biotech Innovation Master Fund Ltd | 10.6% | 13G | Nov 7, 2025 | filing ↗ | |
| Farallon Capital Management, L.L.C. | 8.3% | 13G | Aug 14, 2026 | filing ↗ | |
| Joshua J. Dapice | 8.3% | 13G | Aug 14, 2026 | filing ↗ | |
| Dreyfuss, Philip D. | 8.3% | 13G | Aug 14, 2026 | filing ↗ | |
| Hannah E. Dunn | 8.3% | 13G | Aug 14, 2026 | filing ↗ | |
| Gehani, Varun N. | 8.3% | 13G | Aug 14, 2026 | filing ↗ | |
| Giauque, Nicolas | 8.3% | 13G | Aug 14, 2026 | filing ↗ | |
| Husen, Avner A. | 8.3% | 13G | Aug 14, 2026 | filing ↗ | |
| KIM, David T. | 8.3% | 13G | Aug 14, 2026 | filing ↗ | |
| LINN, Michael G. | 8.3% | 13G | Aug 14, 2026 | filing ↗ | |
| LUO Patrick (CHENG) | 8.3% | 13G | Aug 14, 2026 | filing ↗ | |
| Roberts, JR., Thomas G. | 8.3% | 13G | Aug 14, 2026 | filing ↗ | |
| Edric C. Saito | 8.3% | 13G | Aug 14, 2026 | filing ↗ | |
| Daniel S. Short | 8.3% | 13G | Aug 14, 2026 | filing ↗ | |
| Spokes, Andrew J. M. | 8.3% | 13G | Aug 14, 2026 | filing ↗ | |
| Warren, JOHN R. | 8.3% | 13G | Aug 14, 2026 | filing ↗ | |
| Wehrly, MARK C. | 8.3% | 13G | Aug 14, 2026 | filing ↗ | |
| BlackRock, Inc. | 7.8% | 13G | Apr 17, 2025 | filing ↗ | |
| JAY R. LULY, PH.D. | 7.7% | 13D | Feb 12, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Jay R. Luly | $68K | Dec 5, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Aug 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 10, 2026 | filing ↗ |
| Material agreement (1.01) | Jul 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 2, 2026 | filing ↗ |
| Other events (8.01) | Jun 23, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 18, 2026 | filing ↗ |
| Earnings (2.02) | May 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 11, 2026 | filing ↗ |
| Other events (8.01) | Mar 20, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 11, 2026 | filing ↗ |
| Shareholder vote (5.07) | Mar 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 11, 2026 | filing ↗ |
| Earnings (2.02) | Feb 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 9, 2026 | filing ↗ |
| Earnings (2.02) | Nov 17, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 17, 2025 | filing ↗ |
| Other events (8.01) | Sep 30, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 30, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Sep 29, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 29, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Sep 29, 2025 | filing ↗ |
| Other events (8.01) | Sep 29, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 29, 2025 | filing ↗ |